The San Diego-based company is developing a continuous glucose monitoring Patch and if the technology can get approved, it would compete against offerings from much larger players in the space like Dexcom, Abbott Laboratories, Medtronic, and Senseonics.
The Cuff to Cloud experience will instantly and effortlessly upload readings to the company’s database, which will then deliver a real-time and personalized message to its members.
The Redwood City, CA-based company said it would acquire Bellwether Bio, which is focused on improving oncology patient care through pioneering research into the epigenomic content of cell free DNA.
The federal agency’s recommendations call for physicians to give women more information about the cancer risks associated with dense breasts.
XSurgical is developing a remote-controlled surgical robot that could potentially be deployed in situations of disaster recovery, battlefields, and space.
FDA is carefully monitoring the medical device supply chain amid a shutdown of facilities that use a gas called ethylene oxide to sterilize medical devices.
The patent infringement suit was filed by CareDx and is over the non-invasive monitoring for organ transplant rejection through cell-free DNA analysis.
WeHealth and PathMaker Neurosystems have formed an alliance to develop the first neuromodulation technology to treat spasticity.
Against the odds, Zimmer Biomet is the first company to gain FDA clearance for brain, spine, and knee offerings on one robotic platform.
Impulse Dynamics, one of 16 private companies Canaccord Genuity named ‘promising’ in a January analyst report, has received approval for the Optimizer Smart System.
The Department of Homeland Security and FDA alerted people about cybersecurity vulnerabilities affecting Medtronic's implantable defibrillators. Medtronic is developing updates to further mitigate these vulnerabilities.
The diagnostic testing community will be able to use it as a resource for a variety of applications, including assay development, test validation, and quality control.